Preliminary Q1 2026 Results: Revenue and Operating Profit Decline, Net Income Turns Positive
- Consolidated preliminary Q1 2026 results: Revenue 235.5bn KRW (YoY -11.1%), Operating profit 2.9bn (-41.1%), Net income 2.2bn (swing to profit)
- QoQ changes: Revenue -6.0%, Operating profit -25.1%, Net income -33.7% (previous quarter net income 33.3bn)
- Controlling interests net income 14.5bn (swing from -66.2bn in prior year same period)
- Figures are preliminary and unaudited, subject to change
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
- Company: Green Cross Medical Science (142280)
- Submission: Green Cross Medical Science Corporation
- Receipt: 05-07-2026
- Under KRX KOSDAQ Market Division